B+
Bull case
15%
Probability
Target price
$53.00
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
GSK
GSKCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Execution on late‑stage pipeline readouts and positive FY2026 guidance drive re-rating to analyst high (near $53); successful commercial traction and favorable regulatory outcomes widen multiples.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Adverse clinical or regulatory outcomes for key pipeline assets
Momentum
64
Value
67
Sentiment
31
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $45.50 · Bull $53.00 · Bear $15.00Analysis 2026-01-31; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-31 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $56.34
Why
Momentum64 · Δ7d -11.8
Value67 · Δ7d -0.2
Sentiment31 · Δ7d -1.5
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • Adverse clinical or regulatory outcomes for key pipeline assets
- • Earnings/guidance miss on 2026-02-04
- • Earnings or guidance miss, adverse regulatory decisions, or material pipeline failures trigger a steep re-rating toward the low ($15 in analyst universe), amplified by investor rotation out of defensive healthcare positions.
Catalyst clock
2026-02-04
FY2025 results and guidance release
Lead driver: Value · See fundamentals
Momentum
64
8% active weight
Current posture
7d trendSoftening
Δ7d
-11.8
Δ21d
+5.1
Value
67
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-1.2
Sentiment
31
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-11.5
Why this grade
Composite grade C. Momentum 64.2 / Value 66.8 / Sentiment 30.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-31. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$45.50
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$15.00
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$101.72B
Beta
0.68
Shares Out
2B
P/E (TTM)
13.6
P/S (TTM)
2.31
P/FCF (TTM)
34.24
Rev YoY
+5.9%
EPS YoY
-69.3%
Gross Margin
+73.3%
Op Margin
+25.0%
Net Debt
$19.25B
Current Ratio
0.82
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data